Phase II study of oral menogaril as first line chemotherapy for advanced breast cancer: A National Cancer Institute of Canada Clinical Trials Group Study-Reference-Cited by-同舟云学术

Phase II study of oral menogaril as first line chemotherapy for advanced breast cancer: A National Cancer Institute of Canada Clinical Trials Group Study

Published:1992-03 Issue:3 Volume:3 Page:201-204
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Stewart D.J.,Eisenhauer E.A.,Skillings J.,Pritchard K.I.,Buckman R.,Vandenberg T.,Verma S.,Aitken S.,Norris B.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/3/3/201/588781/3-3-201.pdf

Reference18 articles.

1. Controlled evaluation of adriamycin (NCS-123127) in patients with disseminated breast cancer;Ahmann,1974

2. Combination chemotherapy and adriamycin in patients with advanced breast cancer;Hoogstraten;Cancer,1976

3. Superiority of adriamycin over oral nitrosoureas in patients with advanced breast carcinoma;Gottlieb;Cancer,1974

4. Chemotherapy of advanced breast cancer: a randomized trial of vincristine, adriamycin, and cyclophosphamide (VAC) versus cyclophosphamide, methotrexate, 5-fluorouracil, and prednisone (CMFP);Carmo-Pereira;Cancer,1981

5. The cardiotoxiciy of anticancer agents;Von Hoff;Semin Oncol,1982

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preclinical Evaluation of New Anthracyclines;Current Medicinal Chemistry;2001-01-01

2. Short-term adverse effects in humans of ingested mineral oils, their additives and possible contaminants–A review;Human & Experimental Toxicology;2000-03

3. Studies on the Synthesis of the C-Glycosidic Part of Nogalamycin, Part 1;Journal of Carbohydrate Chemistry;1998-03-01

4. Section Review Oncologic, Endocrine & Metabolic: Recent developments with novel anthracyclines for the treatment of haematological malignancies;Expert Opinion on Investigational Drugs;1996-12

5. Clinical cooperative trials of the national cancer institute of Canada clinical trials group breast cancer site group;Cancer;1994-08-01